KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Assets (2018 - 2025)

Amneal Pharmaceuticals (AMRX) has 5 years of Return on Assets data on record, last reported at 0.02% in Q4 2024.

  • For Q4 2024, Return on Assets changed N/A year-over-year to 0.02%; the TTM value through Dec 2024 reached 0.02%, changed N/A, while the annual FY2024 figure was 0.02%, 1.0% down from the prior year.
  • Return on Assets reached 0.02% in Q4 2024 per AMRX's latest filing, up from 0.04% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q4 2021 and bottomed at 0.09% in Q1 2020.
  • Average Return on Assets over 4 years is 0.04%, with a median of 0.03% recorded in 2024.
  • Peak YoY movement for Return on Assets: increased 8bps in 2021, then dropped -7bps in 2022.
  • A 4-year view of Return on Assets shows it stood at 0.09% in 2020, then skyrocketed by 106bps to 0.01% in 2021, then plummeted by -1403bps to 0.07% in 2022, then soared by 68bps to 0.02% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.02% in Q4 2024, 0.04% in Q3 2024, and 0.07% in Q4 2022.